-
EP1113794
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1113794
| EP1113794 - METHODS OF TREATING VIRAL DISEASE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.08.2006 Database last updated on 24.08.2024 | Most recent event Tooltip | 25.07.2008 | Change - representative | published on 27.08.2008 [2008/35] | Applicant(s) | For all designated states VERTEX PHARMACEUTICALS INCORPORATED 130 Waverly Street Cambridge, MA 02139-4242 / US | [2001/28] | Inventor(s) | 01 /
TUNG, Roger 54 Richfield Road Arlington, MA 01274 / US | 02 /
KWONG, Ann 45 Sunset Road Cambridge, MA 02138 / US | [2001/28] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2001/28] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | Application number, filing date | 99969023.3 | 14.09.1999 | [2001/28] | WO1999US21003 | Priority number, date | US19980100144P | 14.09.1998 Original published format: US 100144 P | US19990138429P | 10.06.1999 Original published format: US 138429 P | [2001/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0015210 | Date: | 23.03.2000 | Language: | EN | [2000/12] | Type: | A2 Application without search report | No.: | EP1113794 | Date: | 11.07.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.03.2000 takes the place of the publication of the European patent application. | [2001/28] | Search report(s) | International search report - published on: | EP | 25.05.2000 | Classification | IPC: | A61K31/365, A61K38/21 | [2001/28] | CPC: |
A61K31/365 (EP);
A61K38/212 (EP);
A61P31/12 (EP);
A61P31/20 (EP);
Y02A50/30 (EP)
| C-Set: |
A61K38/212, A61K2300/00 (EP);
A61K38/212, A61K31/365 (EP) | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/28] | Extension states | AL | 11.04.2001 | LT | 11.04.2001 | LV | 11.04.2001 | MK | 11.04.2001 | RO | 11.04.2001 | SI | 11.04.2001 | Title | German: | VERWENDUNG VON MYCOPHENOLSÄURE UND MYCOPHENOLSÄUREDERIVATE ZUR BEHANDLUNG VON VIRUSERKRANKUNGEN | [2001/28] | English: | METHODS OF TREATING VIRAL DISEASE | [2001/28] | French: | PROC D POUR TRAITER UNE MALADIE VIRALE | [2001/28] | Entry into regional phase | 11.04.2001 | National basic fee paid | 11.04.2001 | Designation fee(s) paid | 11.04.2001 | Examination fee paid | Examination procedure | 13.04.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 11.04.2001 | Amendment by applicant (claims and/or description) | 11.04.2001 | Examination requested [2001/28] | 16.04.2004 | Despatch of a communication from the examining division (Time limit: M07) | 25.11.2004 | Reply to a communication from the examining division | 06.12.2005 | Despatch of a communication from the examining division (Time limit: M04) | 31.03.2006 | Application deemed to be withdrawn, date of legal effect [2006/39] | 05.05.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2006/39] | Fees paid | Renewal fee | 01.10.2001 | Renewal fee patent year 03 | 30.09.2002 | Renewal fee patent year 04 | 30.09.2003 | Renewal fee patent year 05 | 30.09.2004 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 30.09.2001 | 03 M06 Not yet paid | 30.09.2005 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DXY]US5688529 (LIDGATE DEBORAH MARILYN [US], et al) [DX] 1,6 * column 12, lines 54,61; claim - * * column 13, line 39 * [Y] 2-5; | [DX]US5444072 (PATTERSON JOHN W [US], et al) [DX] 1,6 * column 1, line 68 * * column 66, lines 27,28 * * column 66, lines 35,36 * * column 67, lines 15,16 *; | [Y]WO9716204 (SCHERING CORP [US]) [Y] 2-5 * example -; claim - *; | [PY]WO9848840 (SCHERING CORP [US]) [PY] 2-5 * the whole document *; | [X] - GONG, Z. J. ET AL, "Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in cultures of primary and immortalized human hepatocytes.", HEPATOLOGY, (1997) VOL. 26, NO. 4 PART 2, PP. 226A. MEETING INFO.: 48TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES CHICAGO, ILLINOIS, USA NOVEMBER 7-11, 1997, XP000889646 [X] 1,4-6 * the whole document * | [X] - PLATZ K P ET AL, "Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.", TRANSPLANTATION PROCEEDINGS, (1998 JUN) 30 (4) 1468-9., XP000889647 [X] 1,4-6 * page 1469, columns 1-2 * DOI: http://dx.doi.org/10.1016/S0041-1345(98)00319-4 | [X] - PLATZ K P ET AL, "Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.", TRANSPLANTATION PROCEEDINGS, (1998 AUG) 30 (5) 2232-3., XP000889658 [X] 1,4-6 * page 2233, column 2 * DOI: http://dx.doi.org/10.1016/S0041-1345(98)00602-2 | [X] - GONG, Z. J. (1) ET AL, "Differential anti - hepatitis B virus activity in vitro of three potent of inosine monophosphate dehydrogenase inhibitors: Mycophenolic acid ( MPA ), 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide ( EICAR ) and ribavirin.", JOURNAL OF HEPATOLOGY, (1998) VOL. 28, NO. SUPPL. 1, PP. 103. MEETING INFO.: 33RD ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER LISBON, PORTUGAL APRIL 15-18, 1998 EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER., XP000889851 [X] 1,4-6 * the whole document * DOI: http://dx.doi.org/10.1016/S0168-8278(98)80608-9 |